Multilevel omics for the discovery of biomarkers and therapeutic targets for stroke

Nature Reviews Neurology, Published online: 22 April 2020; doi:10.1038/s41582-020-0350-6In this Review, Montaner and colleagues summarize how proteomics, genomics, transcriptomics and metabolomics are contributing to the discovery and development of biomarkers in stroke, and how bringing them together with integromics could provide new biomarkers and therapeutic opportunities.
Source: Nature Reviews Neurology - Category: Neurology Authors: Source Type: research
More News: Brain | Neurology | Stroke